Monitoring surgical treatment of screen-detected breast lesions in Italy

European Journal of Cancer

Volumn 40, Issue 7, 2004, Pages 1006-1012

  Distante, V ^a   Mano, M P ^b   Ponti, A ^c   Cataliotti, L ^a   Filippini, L ^d   Giorgi, D ^e   Lazzaretti, M G ^f   Marchesi, C ^g   Perfetti, E ^h   Segnan, N ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CPO Piemonte   (Italy)

^d ASL 18   (Italy)

^e CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^f Divisione di Chirurgia Generale   (Italy)

^g PATHOLOGY UNIT   (Italy)

^h Fondo Edo Tempia   (Italy)

Author keywords

Audit system; Breast cancer; Breast lesion; Quality control; Screening; Surgical treatment

Indexed keywords

ARTICLE; BREAST LESION; BREAST SURGERY; CANCER DIAGNOSIS; CARCINOMA IN SITU; COMPARATIVE STUDY; FROZEN SECTION; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; ITALY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MONITORING; PEROPERATIVE CARE; PLANNING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; GUIDELINE ADHERENCE; HUMANS; ITALY; MASS SCREENING; MEDICAL AUDIT; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; REFERENCE STANDARDS; WAITING LISTS;

EID: 11144355161     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.01.015     Document Type: Article

References (20)

1. Quinn M.J., Martinez-Garcia C., Berrino F. Variations in survival from breast cancer in Europe by age and country, 1978-1989 EUROCARE Working Group. Eur. J. Cancer. 34:1998;2204-2211.
2. Corley R.D. Breast cancer. treatment differences and survival JAMA. 272:1994;1167.
3. Richards M., Sainsbury R., Kerr D. Inequalities in breast cancer care and outcome. Br. J. Cancer. 76:1997;634-638.
4. Sainsbury R., Haward B., Rider L., Johnston C., Round C. Influence of clinical workload and patterns of treatment on survival from breast cancer. Lancet. 345:1995;1265-1270.
5. Roohan P.J., Bickell N.A., Baptiste M.S., Therriault G.D., Ferrara E.P., Siu A.L. Hospital volume differences and five-year survival from breast cancer. Am. J. Public Health. 88:1998;454-457.
6. Blamey R.W. The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Speciality Group. Eur. J. Surg. Oncol. 24:1998;464-476.
7. Forza Operativra Nazionale sul Carcinoma Mammario (FONCaM): I tumori della mammella. Linee guida sulla diagnosi il trattamento e la riabilitazione. Società Italiana di Senologia Firenza marzo 2001.
8. Blicher-Toft M., Smola M.G., Cataliotti L., O'Higgins N. Principles and guidelines for surgeons - management of symptomatic breast cancer. European Sociaety of Surgical Oncology. Eur. J. Surg. Oncol. 23:1997;101-109.
9. O'Higgins N., Linos D.A., Blicher-Toft M.et al. European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group. Eur. J. Surg. Oncol. 24:1998;96-98.
10. Perry N, Broeders M, de Wolf C, Tomberg S, eds. European guidelines for Quality Assurance in Mammography Screening, 3rd edn. European Commission Publication, 2001.
11. Rutgers E.J.Th. for the EUSOMA Consensus Group Quality control in the locoregional treatment of breast cancer. Eur. J. Cancer. 37:2001;447-453.
12. Blamey R., Blichert-Toft M., Cataliotti L.et al. (EUSOMA Working Group) Breast Units. Future Standards and Minimum Requirements Eur. J. Cancer. 36:2000;2288-2293.
13. Ponti A., Segnan N., Blamey R.et al. Data Collection on Treatment of Screen-Detected lesions. Perry N., Broeders M., de Wolf C., Tornberg S., Schouten J. European Guidelines for Quality Assurance in Mammography Screening. 3rd edn. 2001;European Commission, Europe Against Cancer Programme, Luxembourg.
14. Blamey R. Accreditation of breast units in Europe and the path to quality standards. Eur. J. Cancer. 36(Suppl. 5):2000;S2-S3.
15. Richards M.A., Smith P., Ramirez A.J., Fentiman I.S., Rubens R.D. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br. J. Cancer. 79:1999;858-864.
16. Perry N.M. on behalf of the EUSOMA Working Party Quality assurance in the diagnosis of breast disease. Eur. J. Cancer. 37:2001;159-172.
17. Guidelines to Cytology Procedures and Reporting in Breast Cancer Screening. NHSBSP Pubblication No. 22, 1993.
18. Park C.C., Mitsumori M., Nixon A.et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer. influence of margin status and systemic therapy on local recurrence J. Clin. Oncol. 18:2000;1668-1675.
19. Smith T.J., Hillner B.E. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J. Clin. Oncol. 19:2001;2886-2897.
20. Cady B., Falkenberry S.S., Chung M.A. The surgeon's role in outcome in contemporary breast cancer. Surg. Oncol. Clin. N. Am. 9:2000;119-132.